The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Slow editing of protein blueprints leads to cell death, spliceosome study discovers
An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...